The extended agreement covers any European country
RA'ANANA, Israel, Aug. 29, 2023 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq:IINN) (Nasdaq: IINNW) (the "Company" or "Inspira"), a company dedicated to advancing acute respiratory care by enabling breathing without lungs, announced today that it has signed a further Service Agreement to supplement its previously announced Strategic Agreement with Innovimed Sp. z o.o ("Innovimed") for planned clinical trials (clinical pilot studies) of the INSPIRA™ ART medical devices.
Read more at prnewswire.com
/A%20close-up%20of%20a%20SpaceX%20sign%20by%20Sundry%20Photography%20via%20Adobe%20Stock.jpeg)
/AI%20(artificial%20intelligence)/AI%20chip%20by%203Dsss%20via%20Shutterstock.jpg)
